Watson-Marlow Flexicon's FPC50 aseptic filling system
The Watson-Marlow Flexicon FPC50 aseptic filling system with integrated plugging, crimp capping and check weighing of vials, delivers fill volumes from 0.1 mL to 100 mL with filling accuracy of ± 0.5%, and is ideal for small batch filling operations.
Fast filling with accuracy of ± 0.5%
Extending validation periods and reducing costs in aseptic and sterile processes is an important aspect of product development at filling and dispensing specialist Watson-Marlow Flexicon.
The company’s FPC50 automated vial filling, plugging and capping system offers a number of advantages that include: no cleaning validation; easy product changeover; no cross contamination; and high accuracy peristaltic filling better than ±0.5% for filling volumes ranging from 0.1ml to 100ml, ensuring substantial annual savings. The unit can fill up to 25 vials per minute and is designed purposely to integrate into an LAF cabinet or an isolator.
The filling system is now available with new DAFPA single-use filling accessories comprising, peristaltic pump tube, filling nozzle and fluid bag if required. All are radiation sterilized, supplied double bagged and Gamma irradiated, ready for use.
Clinical/sterile environments are a common application for the peristaltic technology offered by Watson-Marlow Flexicon. The peristaltic filling system on the FPC50 not only avoids the problems of cross-contamination, it eliminates the costs and difficulties of having product and volume-dedicated volumetric filling pumps in stock. With the entire fluid path designed for single use, all historical documentation related to volumetric pumps is unnecessary, making cleaning validation extremely simple.
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of On-Demand Manufacturing and Derisking in Accelerating Early Clinical Trial Success
June 4th 2025Small pharmaceutical companies are constantly seeking innovative solutions to streamline early clinical trials. Adaptive clinical trials offer important benefits to sponsors and patients, both from a commercial and ethical standpoint. These trials offer flexibility and efficiency, especially in the early stages, where trial protocols can be adjusted based on interim data, such as introducing new doses or modifying participant sample size. However, adjusting manufacturing demand during an adaptive trial can be complicated, and strict regulatory requirements present significant challenges. On-demand manufacturing provides a robust solution, allowing for real-time supply and demand adjustments and improved trial flexibility. This paper explores how on-demand manufacturing meets the operational needs of adaptive trials and aligns with regulatory expectations.
